Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Pliva prepares new macrolide antibiotics

June 17, 1997

Natural remedy for the common cold evaluated in controlled clinical trial

June 16, 1997

Valaciclovir has comparable efficacy and safety to aciclovir in recurrent genital herpes

June 16, 1997

Pharmacokinetics of DW-116, ciprofloxacin and rufloxacin compared in animals

June 16, 1997

In vitro profile of new quinolone: HSR-903

June 16, 1997

AM-1155: in vitro and in vivo antichlamydial activity

June 13, 1997

Bay-12-8039: time-kill and PAE studies

June 13, 1997

Activity of Sch-48973 against enteroviruses

June 13, 1997

D-0870 for AIDS-related oral candidiasis

June 13, 1997

Alfa Wassermann and Merckle sign development and marketing agreement for rifaximin

June 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.